瑞舒伐他汀联合尼可地尔治疗冠状动脉慢血流的临床疗效  

The Clinical Efficacy of Rosuvastatin Combined With Nicorandil on Coronary Slow Flow

作　　者：郭方明[1] 李颖[1] 赵英杰[1] 

机构地区：[1]吉林市中心医院血管二疗区四组,吉林吉林132001

出　　处：《中国卫生标准管理》2016年第13期114-115,共2页China Health Standard Management

摘　　要：目的探讨冠状动脉慢血流采用瑞舒伐他汀联合尼可地尔治疗的临床效果。方法将148例冠状动脉慢血流患者随机分为研究组(瑞舒伐他汀+尼可地尔)与对照组(瑞舒伐他汀),对比两组治疗效果。结果研究组各支冠状动脉血流速度优于对照组(P<0.05);研究组ET-1、hs-CRP低于对照组(P<0.05),NO水平高于对照组(P<0.05)。结论冠状动脉慢血流采用瑞舒伐他汀联合尼可地尔治疗的效果好。Objective To investigate the clinical effect of slow coronary flow by rosuvastatin combined with nicorandil treatment.Methods 148 cases of coronary slow flow patients were randomly divided into study group（rosuvastatin plus nicorandil）and control group （rosuvastatin）,compared to two groups of therapeutic effect.ResultsThe blood flow rate of the study group was better than that of the control group（P〈0.05）. The study group of hs-CRP and ET-1 were significantly lower than the control group（P〈0.05）, and the level of NO was higher than that of the control group（P〈0.05）.Conclusion Slow coronary flow by rosuvastatin combined with nicorandil treatment of effect is remarkable.

关 键 词：冠状动脉慢血流 瑞舒伐他汀 尼可地尔 

分 类 号：R541.4[医药卫生—心血管疾病]